Standardizing Starting Material Labeling & Chain of Identity to Strengthen Traceability Across Cell Therapy Supply Chains
2:30 pm - Monday 7th December 2026
- Understanding current cchain of identity requirements to ensure compliance with evolving FACT-JACIE expectations and industry best practices for donor material traceability
- Implementing the ISBT 128 chain of identity identifier standard to create globally unique identifiers, improve interoperability, and reduce errors across clinical and manufacturing workflows
- Maintaining end-to-end traceability through standardized labeling to strengthen patient safety, support biovigilance investigations, and enable efficient product tracking from donor to patient
